If Orexigen wins FDA approval for its new weight loss drug, how will it and its pharma partner Takeda take on the obesity market? After all, it's an area where two recent debuts are struggling for recognition. Report
There are many factors that can play a major role in the success or failure of a clinical trial and the long term efficacy of a cell-based commercial product. This eBook goes beyond the basics and focuses on the unique logistical challenges of autologous cellular therapies. Download free ebook now!
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 150,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!